Regulatory FDA Expands AI Capabilities and Completes Data Platform Consolidation FDAFDA announced major steps in its bold initiative to modernize the agency.Read full story pharminent May 6, 2026 (Last updated: May 7, 2026) FDA FDA announced major steps in its bold initiative to modernize the agency. Read full story Post navigation Previous: Bayer to buy Perfuse for up to $2.45B, bolstering eye drug pipelineNext: Halozyme and Oruka sign agreement for Hypercon technology Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026